|
Report Date : |
05.06.2014 |
IDENTIFICATION DETAILS
|
Name : |
PHARM CARES CO. |
|
|
|
|
Registered Office : |
66-11, Byeoryang-ro, Gwacheon-si,
Gyeonggi-do, Suite 348-502, Samsung-Reamian Apt., Zip Code
427-802 |
|
|
|
|
Country : |
South Korea |
|
|
|
|
Date of Incorporation : |
Not Available |
|
|
|
|
Com. Reg. No.: |
Not Available |
|
|
|
|
Legal Form : |
Sole Proprietorship |
|
|
|
|
Line of Business : |
Wholesaler of Pharmaceutical Products |
|
|
|
|
No of Employees : |
01 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2014
|
Country Name |
Previous Rating (31.12.2013) |
Current Rating (31.03.2014) |
|
South korea
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
South Korea ECONOMIC OVERVIEW
South Korea over the past four decades has demonstrated
incredible growth and global integration to become a high-tech industrialized
economy. In the 1960s, GDP per capita was comparable with levels in the poorer
countries of Africa and Asia. In 2004, South Korea joined the trillion dollar
club of world economies, and is currently the world's 12th largest economy.
Initially, a system of close government and business ties, including directed
credit and import restrictions, made this success possible. The government
promoted the import of raw materials and technology at the expense of consumer
goods, and encouraged savings and investment over consumption. The Asian
financial crisis of 1997-98 exposed longstanding weaknesses in South Korea's
development model including high debt/equity ratios and massive short-term
foreign borrowing. GDP plunged by 6.9% in 1998, and then recovered by 9% in
1999-2000. Korea adopted numerous economic reforms following the crisis,
including greater openness to foreign investment and imports. Growth moderated
to about 4% annually between 2003 and 2007. Korea's export focused economy was
hit hard by the 2008 global economic downturn, but quickly rebounded in
subsequent years, reaching 6.3% growth in 2010. The US-South Korea Free Trade
Agreement was ratified by both governments in 2011 and went into effect in
March 2012. Throughout 2012 and 2013 the economy experienced sluggish growth
because of market slowdowns in the United States, China, and the Eurozone. The
administration in 2014 is likely to face the challenge of balancing heavy
reliance on exports with developing domestic-oriented sectors, such as
services. The South Korean economy's long term challenges include a rapidly
aging population, inflexible labor market, and heavy reliance on exports -
which comprise about half of GDP.
|
Source : CIA |
|
Concern Name |
PHARM CARES CO. (Korean Concern Name : “팜케어스”) |
|
Registered Address |
66-11, Byeoryang-ro, Gwacheon-si,
Gyeonggi-do, Korea |
|
Building |
Suite
348-502, Samsung-Reamian Apt. |
|
Zip Code |
427-802 |
|
Tel |
N/A |
|
Fax |
N/A |
|
E-mail |
|
|
Trading
Address |
Suite 348-502, Samsung-Reamian Apt., 66-11, Byeoryang-ro, Gwacheon-si, Gyeonggi-do, Korea (Old Address System : Suite 348-502, Samsung-Reamian Apt., 17, Byeoryang-dong, Gwacheon-si, Gyeonggi-do, Korea) |
|
Tel |
N/A |
|
Fax |
N/A |
|
Type |
Import |
|
Industry |
Wholesaler of Pharmaceutical Products |
|
Main Business |
Pharmaceutical Products |
|
Established (mm/dd/yyyy) |
N/A |
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Pharmaceutical Products |
|
Sell |
Packing
Materials |
|
Name |
Kim Hyun-Jong(Mobile : +82-10-6334-5582) |
|
Address |
Suite
348-502, Samsung-Reamian Apt., 17, Byeoryang-dong,
Gwacheon-si, Gyeonggi-do, Korea |
|
Date of Birth |
01/08/1971 |
|
Title |
Owner |
|
Sex |
Male |
|
Nationality |
Korean |
|
Capital (KRW) |
Not Applicable to
the Sole Proprietorship |
|
Employees |
1 |
|
Formation |
Sole
Proprietorship |
|
Bank Details |
Woori Bank Hana
Bank-Gwacheon Branch |
|
Corporate Registered No. |
Not Applicable to the Sole Proprietorship |
|
Business Registered No. |
N/A. (The numbers are kept by the National
Tax Service confidentially.) Because the subject’s full Business
Registered No., for checking through the National Tax Service whether the
subject is still existing or not, is not available, so we cannot confirm if
the subject exist or not legally.) |
|
Permit & Licenses |
N/A |
|
Shareholder Position |
The owner has 100% shares. |
|
Concern History |
N/A |
In our research through
the official sources including the Supreme Court Registry at which every Co Ltd
type of Concern should be registered, we could not find the subject concern. So
we submit the report as a Sole Proprietorship Type of Concern as long as it
exists.
The premises at Suite 348-502,
Samsung-Reamian Apt., 17, Byeoryang-dong, Gwacheon-si,
Gyeonggi-do, Korea had been owned by Mr. Kim
Hyun-Jong(DOB : 01/08/1971) and M/S. Bae Mi-Hyun(DOB : 07/10/1973) until
03/22/2013. And they sold the premises to Mr. Lee Jong-Hwan(DOB : 05/15/1932)
and M/S. Choi Myung-Hee(DOB : 09/12/1938).
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Date |
|
Owner |
Mr. |
Kim Hyun-Jong |
Male |
Korean |
N/A |
The financials are not
available, and the Subject Concern does not have any obligations to release its
financials to the public.
|
Authorized Capital(KRW) |
Not
Applicable to the Sole Proprietorship |
|
Paid-Up Capital(KRW) |
Not
Applicable to the Sole Proprietorship |
|
Total Issues Shares |
Not
Applicable to the Sole Proprietorship |
|
Main Products & Services |
Pharmaceutical Products |
|
Competitors |
HIGH TECH PHARM. CO., LTD. 576-1, SEONGBON-RI, DAESO-MYEON,
EUMSEONG-GUN, CHUNGCHEONGBUK-DO, KOREA TEL:+82-43-883-0012 FAX:+82-43-883-0014 HANSEO CHEM CO., LTD. 2-DANJI, POSEUNG NATIONAL INDUSTRIAL COMPLEX,
1206-14, WONJEONG-RI, POSEUNG-EUP, PYEONGTAEK-SI, GYEONGGI-DO, KOREA TEL:+82-31-682-8655 FAX:+82-31-682-8656 DAEBONG LS CO., LTD. 122B-9L, NAMDONG INDUSTRIAL COMPLEX, 692-8,
GOJAN-DONG, NAMDONG-GU, INCHEON, KOREA TEL:+82-32-817-8800~7 FAX:+82-32-817-8808 |
(Activity &
Markets)
The Subject imports
from India.
Not Available.
---
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.59.34 |
|
UK Pound |
1 |
Rs.99.18 |
|
Euro |
1 |
Rs.80.76 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUM |
|
|
|
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.